The AT2R generally exerts actions antagonistic to the AT1R including inhibition of proliferation and angiogenesis [9,10] and promotion of apoptosis [11] and while AT1R blockade has been extensively studied in the context of cancer treatment, the potential of targeting the AT2R in cancer has not been investigated. This evidence concerns the gene AGTR1 and cancer.